Skip to content

Alinity 08P3210

by Abbott

Part of a family of 7 devices: see the family page

Ref 08P3210

Alinity 08P3210 is an in vitro diagnostic device (EU IVDR Class C; FDA Class I; FDA product code JJX, Single (specified) analyte controls (assayed and unassayed)) made by Abbott, registered in EUDAMED on 24 Aug 2026 (Basic UDI-DI 038074AIP0832LA) and listed in FDA GUDID since 3 Jan 2019 (UDI-DI 00380740135492), active as of 23 Oct 2026.

Active European Union. Also listed in GUDID (US).

CE IVDR

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR EUDAMED Number038074AIP0832LA Basic UDI-DI 00380740135492UDI-DIDate24 Aug 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number00380740135492 UDI-DI Date3 Jan 2019ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
Alinity i CA 19-9XR Controls
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • EUDAMED Basic UDI-DI 038074AIP0832LA registered 24 Aug 2026 Active
  • FDA GUDID UDI-DI 00380740135492 listed 3 Jan 2019 Listed

Timeline

2 dated events

  1. Listed FDA GUDID 00380740135492
  2. Registered EUDAMED 038074AIP0832LA

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDR Active
  • United States GUDID listing Listed

Specification

EUDAMED · GUDID

Trade name
Alinity
Generic name
Cancer antigen 19-9 (CA19-9) IVD, control
Device name
Alinity i CA19-9XR
Model / Ref / Catalog
08P3210
Primary DI / UDI-DI
00380740135492
Basic UDI-DI
038074AIP0832LA
FDA product code
JJX
EMDN code
W0102152005 Tumour marker controls
GMDN term
Cancer antigen 19-9 (CA19-9) IVD, control
Device class
Class C EUDAMED
Class I GUDID
Regulation number
862.1660
EU registration type
Standard device
EU market of registration
Germany
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class C
GUDID
Class I

Device class is stated on each registry's own scale: Class C in the EU (EUDAMED), Class I in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under TUMOUR MARKER CONTROLS.

Other devices from Abbott

See all devices from Abbott →

Properties

  • Contains human tissues or cells
  • Contains animal tissues or cells
  • Reagent
  • IVD kit
  • Professional testing
  • Prescription use
  • Convenience kit
  • Premarket exempt
  • Lot / batch number
  • Expiration date
Other properties (16, all answered No)